EUVIMEDEUVIMED entdecken
Leserbrief

Author Response to “Interpreting romosozumab for cancer treatment-induced bone loss: measurement, missing data, and surveillance”

Hirotaka Koyanagi, Shohei Tsujino, Chigusa Sawamura, Katsunori Tozuka, Tabu Gokita

Osteoporosis International · 2026-10 · 37 (10) · 2765-2766

DOI: 10.1007/s00198-026-08233-w ↗

Kurz gefasst

Leserbrief in der Zeitschrift Osteoporosis International, online erschienen am 02.10.2026. Verfasst von Hirotaka Koyanagi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation Medicine, Saitama Cancer Center, 780 Komuro, Ina-Machi, Kita-Adachi-Gun, Saitama, 362-0806, Japan. hkoyanagi.orth1003@gm…. Die Arbeit nennt 1 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Rehabilitation Medicine, Saitama Cancer Center, 780 Komuro, Ina-Machi, Kita-Adachi-Gun, Saitama, 362-0806, Japan. hkoyanagi.orth1003@gmail.com.
  • Department of Orthopaedic Surgery, Saitama Cancer Center, Saitama, Japan. hkoyanagi.orth1003@gmail.com.
  • Department of Orthopaedic Surgery, Saitama Cancer Center, Saitama, Japan.
  • Department of Orthopaedic Surgery, Institute of Science Tokyo, Tokyo, Japan.
  • Department of Breast Surgery, Saitama Cancer Center, Saitama, Japan.

Zitieren

APA

Koyanagi, H., Tsujino, S., Sawamura, C., Tozuka, K., & Gokita, T. (2026). Author Response to “Interpreting romosozumab for cancer treatment-induced bone loss: measurement, missing data, and surveillance”. Osteoporosis International, 37(10), 2765-2766. https://doi.org/10.1007/s00198-026-08233-w

Vancouver

Koyanagi H, Tsujino S, Sawamura C, Tozuka K, Gokita T. Author Response to “Interpreting romosozumab for cancer treatment-induced bone loss: measurement, missing data, and surveillance”. Osteoporosis International. 2026;37(10):2765-2766. doi:10.1007/s00198-026-08233-w

BibTeX
@article{Koyanagi2026,
  author = {Koyanagi, Hirotaka and Tsujino, Shohei and Sawamura, Chigusa and Tozuka, Katsunori and Gokita, Tabu},
  title = {Author Response to “Interpreting romosozumab for cancer treatment-induced bone loss: measurement, missing data, and surveillance”},
  journal = {Osteoporosis International},
  year = {2026},
  volume = {37},
  number = {10},
  pages = {2765--2766},
  doi = {10.1007/s00198-026-08233-w}
}
Kostenlos starten →